logo
2nd child from Ingham County has measles after exposure to baby girl with virus

2nd child from Ingham County has measles after exposure to baby girl with virus

Yahoo24-04-2025

A 1-year-old boy in Ingham County now has the measles, state and county health officials announced April 23, one day after confirming that he was infected following exposure to a 12-month-old girl who also has the highly contagious virus.
The boy's family was contacted by communicable disease nurses from the Ingham County Health Department after he was exposed to the 12-month-old girl, whose measles infection was confirmed April 15. When he developed symptoms, he was immediately tested.
The boy was vaccinated with an age-appropriate one dose of the measles, mumps, rubella (MMR) vaccine, Dr. Nike Shoyinka, the county's medical health officer, said in a statement. But the single dose wasn't enough to fully protect him from illness. His symptoms, however, are mild.
'We understand that news of another case may cause concern in our community,' Shoyinka said. 'However, this child's vaccination status helped lessen the severity of illness, and early isolation significantly reduced the risk of transmission.
"This case highlights the importance of timely vaccinations and swift public health response.'
This is at least the eighth confirmed measles case in Michigan so far this year. An outbreak was declared April 17 in Montcalm County, and an additional case in Eaton County is still awaiting confirmation, said Emily Smale, a spokesperson from the Barry-Eaton District Health Department told the Free Press.
The Ingham County boy with measles may have exposed others to the virus between 4:30 p.m.-7 p.m. April 15 at Lansing Urgent Care – Frandor, 505 N. Clippert St., Lansing.
Anyone who was at the urgent care center during that time is asked to monitor for symptoms of measles for 21 days from the date of exposure, and should call a doctor if symptoms develop before seeking treatment to ensure precautions can be taken to prevent further exposure.
Measles is so contagious that even after a person infected with the virus leaves a room, 90% of people without immunity to the virus will get sick if they enter the room for up to two hours later. Additionally, a person can be infectious and spreading the disease for as many as four days before the telltale rash develops and for four days after the rash begins, according to the CDC.
According to the U.S. Centers for Disease Control and Prevention, measles symptoms typically start within seven to 14 days of exposure, but also have been known to appear as long as 21 days after initial exposure and can include:
Fever, which may rise above 104 degrees.
Respiratory symptoms such as runny nose and cough.
Red, watery eyes that can develop into pink eye or conjunctivitis.
Two to three days after symptoms begin, tiny white spots, known as Koplik spots, may develop on the inner cheeks, gums and roof of the mouth.
Three to five days after symptoms begin, a rash that is red, raised and blotchy appears. It usually begins on the face and spreads to the trunk, arms and legs.
Measles can cause serious illness, long-term disability and death in people of all ages.
So far this year, 85 people in the U.S. with confirmed measles cases have been hospitalized for treatment — that's about 11% of the 800 confirmed infections nationally as of April 17. The vast majority — 68 of the 85 who were hospitalized — were younger than the age of 20, according to the CDC.
About 1 in 20 children with measles develops pneumonia. Roughly 1 out of every 1,000 children with measles infections will also have encephalitis. Brain swelling from encephalitis can lead to convulsions, permanent hearing loss, intellectual disability and death, according to the CDC.
Anywhere from 1 to 3 of every 1,000 children with measles dies from respiratory or neurologic complications from the virus.
People who contract measles during pregnancy also are more likely to develop pneumonia and be hospitalized. The virus can cause miscarriage and stillbirth as well as trigger preterm birth and lead to lower birth weights, according to the CDC.
The CDC has confirmed two deaths from measles in the U.S. this year. A third death remains under investigation.
More: Michigan baby had measles vaccine 1 day before trip to airport with contagious traveler
"Our recommendation is for everyone to be vaccinated," Shoyinka said in a previous interview.
One dose of the MMR vaccine provides about 93% protection against the virus, and two doses offer about 97% coverage, the CDC says. It recommends the following for MMR vaccines:
A first dose for children at 12-15 months old, with a booster dose administered between ages 4 and 6.
Anyone born during or after 1957 without evidence of immunity against measles or documentation of having been vaccinated with two doses of MMR vaccine should get vaccinated. The second dose should be given no sooner than 28 days after the first.
People exposed to measles who cannot document immunity against the virus should get post-exposure prophylaxis — a dose of the vaccine to potentially provide protection within 72 hours of initial exposure, or immunoglobulin within six days of exposure.
The CDC changed its recommendations in 1989 from one dose of the MMR vaccine to two doses, which provides longer-lasting and more robust protection. People born between 1957 and 1989 who have had just a single dose of the vaccine may be at a higher risk of contracting the virus in an outbreak setting.
Ingham County residents can get an MMR vaccine at the health department's immunization clinic, 303 S. Cedar St., Lansing. (Use entrance No. 3 when entering the building and go to the second floor.) Walk in hours are:
9:30 a.m.-4 p.m. Mondays, Tuesdays and Fridays.
9:30 a.m.-5:30 p.m. Wednesdays.
1-4 p.m. Thursdays.
Call the health department at 517-887-4316 or email Immunization@ingham.org to make an appointment.
Both county and state health officials said they are continuing efforts to trace the child's contacts and identify others who may have been been exposed.
Contact Kristen Shamus: kshamus@freepress.com. Subscribe to the Free Press.
This article originally appeared on Detroit Free Press: Ingham County reports 2nd measles case in 1-year-old boy

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US measles cases nearing 30-year high

time2 hours ago

US measles cases nearing 30-year high

The number of measles cases in the U.S. this year has quadrupled compared to 2024 and is nearing a 30-year high. As of Friday, there have been 1,168 confirmed measles cases across 33 states nationwide, according to data from the Centers for Disease Control and Prevention. Last year, the U.S. saw just 285 measles cases, CDC data shows. The U.S. is currently on track for the highest number of measles case since 2019. The 33 states with confirmed cases include Alaska, Arkansas, California, Colorado, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Michigan, Minnesota, Missouri, Montana, Nebraska, New Jersey, New Mexico, New York, North Dakota, Ohio, Oklahoma, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Vermont, Virginia and Washington. Among the nationally confirmed cases, the CDC says 95% are among people who are unvaccinated or whose vaccination status is unknown. Meanwhile, 2% of cases are among those who have received just one dose of the measles, mumps, rubella (MMR) vaccine and 3% of cases are among those who received the required two doses, according to the CDC. At least two school-aged children have died. Both were unvaccinated and had no known underlying conditions, according to Texas health officials said. A third measles death was recorded in New Mexico among an unvaccinated adult who tested positive after dying, according to the New Mexico Department of Health.

Georgia health officials confirm new measles case in metro Atlanta area
Georgia health officials confirm new measles case in metro Atlanta area

Yahoo

time3 hours ago

  • Yahoo

Georgia health officials confirm new measles case in metro Atlanta area

The Georgia Department of Public Health confirmed another unvaccinated metro Atlanta resident had been diagnosed with measles. The resident this time is a family member of the person who had been infected with measles while traveling outside of the United States, which was confirmed in May. Health officials say those who may have been in contact or exposed to either of the two individuals who have been confirmed to have measles were given the measles, mumps, rubella (MMR) vaccine or antibodies to help reduce their risk of contracting the disease. Georgia health officials are now monitoring the individuals who came into contact or were exposed to the two metro Atlanta residents with measles for symptoms. [DOWNLOAD: Free WSB-TV News app for alerts as news breaks] RELATED STORIES: State health department confirms new measles case in Georgia Measles cases growing across Georgia, doctors encouraging vaccines Wastewater helping track spread of measles in GA At this time, no new cases of measles have been reported outside of the family, according to GaDPH. Health officials said the MMR vaccine is safe and effective and mentioned that the U.S. Centers for Disease Control and Prevention, which is based in the metro area, recommends that children receive their first dose of the MMR vaccine between 12 to 15 months of age and a second between four and six years old. "More than 95% of the people who receive a single dose of MMR will develop immunity to all three viruses. A second dose boosts immunity, typically enhancing protection to 98%," GaDPH said. The department said this was the fifth case of measles reported in Georgia for 2025. In 2024, there were six cases reported in the state. [SIGN UP: WSB-TV Daily Headlines Newsletter]

WHO sounds the alarm as US measles cases mount
WHO sounds the alarm as US measles cases mount

Politico

time6 hours ago

  • Politico

WHO sounds the alarm as US measles cases mount

Presented by Driving The Day WHO SPEAKS UP ON MEASLES — President Donald Trump might not care for the World Health Organization's advice, but that isn't stopping one of its top officials from warning his administration about what's at stake as measles cases accumulate in the U.S. Dr. Katherine O'Brien, the WHO's vaccines director, told POLITICO's Carmen Paun that U.S. political leaders should clearly endorse and promote measles vaccination to prevent the country from losing its disease-elimination status — and become a location that gives rise to future outbreaks that can easily spread domestically and abroad among travelers. If the disease spreads continuously for a year, it would be considered endemic for the first time in 25 years. 'It's really a sign of a country going backwards in terms of their ability to protect people,' O'Brien said. Why it matters: O'Brien said 'leadership voices really matter' when people consider medical interventions for their children. If one family is influenced enough to decline the measles, mumps and rubella vaccine for their child, that's 'one child too many,' she said, given how highly contagious the virus is. Measles is 'not just a fever and a rash that people get over,' O'Brien said. So far this year, three unvaccinated people — including two young girls — have died from the disease in the U.S. Before the most recent outbreak, the last U.S. measles death occurred in 2015. Background: HHS Secretary Robert F. Kennedy Jr. has couched his promotion of the MMR shot with statements emphasizing that vaccination is a personal choice. Before he ran for president and then entered government, Kennedy founded Children's Health Defense, an anti-vaccine nonprofit that suggests shots cause a slew of pediatric medical problems such as autism, asthma and developmental delays. Kennedy has also inaccurately asserted that the MMR vaccine contains cells from aborted fetuses and has touted supplements like vitamin A as a disease treatment. HHS has defended the secretary's measles response, calling 'claims' that he's 'spreading misinformation or undermining vaccine confidence … flat-out false.' WELCOME TO FRIDAY PULSE. I'm FDA reporter Lauren Gardner, filling in for Kelly today. Pass along your tips, scoops and feedback to lgardner@ and khooper@ and follow along @Gardner_LM or @Kelhoops. POLITICO PRO SPACE — Need an insider's guide to the politics behind the new space race? From battles over sending astronauts to Mars to the ways space companies are vying to influence regulators, this weekly newsletter decodes the personalities, policy and power shaping the final frontier. Find out more. In Congress THIRD RAIL NO MORE? Senate Republicans are considering ways to incorporate Medicare cuts into their domestic spending package to help offset its cost — a move that could divide a party that can't afford many defections to pass the president's signature legislation, POLITICO's Jordain Carney, Meredith Lee Hill and Robert King report. The House version of President Donald Trump's big beautiful bill includes cuts to Medicaid, the government health insurance program for low-income people and those with disabilities. But cuts to Medicare — which insures those 65 and older — are widely seen as politically dangerous. The idea percolated in private meetings this week as GOP leaders try to placate budget hardliners who want more spending cuts in the package ahead of a self-imposed July 4 deadline for passage. And some Republicans believe Trump supports Medicare cuts — provided they're limited to targeting 'waste, fraud and abuse' — despite the potential for backlash from rank-and-file senators and House moderates who already sank efforts to touch the program. HEADING TO THE HUMPHREY BUILDING — The Senate confirmed Jim O'Neill on Thursday in a 52-43 vote to be HHS's deputy secretary, your morning host writes. O'Neill, a George W. Bush-era HHS official who's close with early Trump supporter and tech billionaire Peter Thiel, will be the department's No. 2 official charged with managing operations. AROUND THE AGENCIES FDA'S RARE DISEASE DRUG APPROACH — The FDA's leading biologics regulator said Thursday that he was open to using alternative measurement methods when evaluating rare-disease therapies, combining what he called 'gold-standard science and common sense' in the approval process. 'We will rapidly make available therapies at the first sign or promise of biomedical success or action, but we're also going to follow up overall survival and quality of life on the back end,' Dr. Vinay Prasad, director of the FDA's Center for Biologics Evaluation and Research, said during an agency roundtable on cell and gene therapies. The remarks were notable given Prasad's history of criticizing past FDA approvals of certain treatments, including a controversial Duchenne muscular dystrophy gene therapy and certain cancer drugs, using surrogate markers. Prasad added he's often asked whether he's 'solely' interested in randomized controlled trials and said he's open to a variety of methodologies demonstrating a drug's benefit. Background: His remarks come weeks after he and Commissioner Marty Makary unveiled a new Covid-19 vaccine framework that limits approvals of future formulation changes to people 65 and older and younger individuals with an underlying condition — and requiring new RCTs to prove the shots are safe and effective for young, healthy people. Cell and gene therapies are often discussed in the context of rare diseases as the technologies can address root causes instead of solely managing symptoms. But a condition's rarity hinders a company's ability to conduct a large-scale trial for a drug candidate, an issue with which regulators and industry have long struggled. The FDA launched a rare disease 'hub' last year to better align its drug and biologics regulators in their approach to considering those therapies for the market. NIH LOOKS TO AI — The National Institutes of Health is building an AI strategy to help HHS Secretary Robert F. Kennedy Jr. target chronic disease, POLITICO's Ruth Reader reports. Principal Deputy Director Matthew Memoli announced the plan Thursday, asking the public to weigh in at the Coalition for Health AI's Innovation Summit at Stanford University. NIH wants industry to comment on both the broad approach and the specific actions the administration should take in developing the strategy. The agency plans to create a new website to highlight its AI work. 'Addressing this crisis is going to require large-scale efforts — research that's going to generate large amounts of data — and we are going to need all the tools available to us in order to try to address this,' Memoli said. Names in the News Courtney Rhodes is now head of news and media relations at the U.S. Travel Association. She was previously a spokesperson at the FDA. The Health Resources and Services Administration announced its new 34-member board of directors for the Organ Procurement and Transplantation Network. WHAT WE'RE READING House FDA appropriators advanced their fiscal 2026 spending measure Thursday for the agency and the U.S. Department of Agriculture, POLITICO's David Lim reports. Infectious disease and other medical experts fear HHS's changes to Covid-19 vaccine recommendations will make it more difficult to immunize people by complicating discussions with providers and likely leading to fewer places stocking them, Stat's Helen Branswell writes.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store